This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher (TMO) Q3 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Thermo Fisher's (TMO) PPI Business System and strong execution by its global team enabled the company to deliver strong financial performance for Q3.
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.97% and 0.04%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
The latest trading day saw Thermo Fisher Scientific (TMO) settling at $469.67, representing a +0.52% change from its previous close.
DexCom (DXCM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Thermo Fisher (TMO) in Q3 Earnings?
by Zacks Equity Research
Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and latest launches.
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
by Zacks Equity Research
Investors continue to be optimistic about Thermo Fisher (TMO) due to its impressive acquisition deals and end-market strength.
(TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $482.85, denoting a +0.06% change from the preceding trading day.
Thermo Fisher's (TMO) Strong End Markets and New Buyouts Aid
by Zacks Equity Research
Thermo Fisher (TMO) is registering strong growth in the electron microscopy and chromatography and mass spectrometry businesses in the academic and government end market.
The Zacks Analyst Blog Highlights Live Thermo Fisher Scientific, Advanced Micro Devices, BP, Marsh & McLennan and Palo Alto Networks
by Zacks Equity Research
Live Thermo Fisher Scientific, Advanced Micro Devices, BP, Marsh & McLennan and Palo Alto Networks are part of the Zacks top Analyst Blog.
Top Research Reports for Thermo Fisher Scientific, AMD & BP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Advanced Micro Devices, Inc. (AMD) and BP p.l.c. (BP).
Thermo Fisher Scientific (TMO) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Thermo Fisher Scientific (TMO) settling at $498.55, representing a +0.11% change from its previous close.
Thermo Fisher (TMO) Expands Capabilities in St. Louis Facility
by Zacks Equity Research
Thermo Fisher (TMO) expands manufacturing capacity at the St. Louis site for Biologics treatment.
Thermo Fisher Scientific (TMO) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $498.02 in the latest trading session, marking a -0.88% move from the prior day.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $506.17, moving +0.63% from the previous trading session.
Thermo Fisher Scientific (TMO) Stock Moves -0.8%: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $501.59 in the latest trading session, marking a -0.8% move from the prior day.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Thermo Fisher Scientific (TMO) Stock Moves -0.76%: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $504.89, moving -0.76% from the previous trading session.
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $507.73 in the latest trading session, marking a -1.51% move from the prior day.
Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $510.99, marking a -0.77% move from the previous day.
Thermo Fisher (TMO) to Advance Clinical Research With New Pact
by Zacks Equity Research
Thermo Fisher's clinical research division will aid in increasing community health clinics' capacity to participate in clinical studies.
Thermo Fisher (TMO) Adds New Platform to CTS Product Portfolio
by Zacks Equity Research
Thermo Fisher (TMO) launches the next-generation Gibco CTS Detachable Dynabeads platform.
Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $536.70 in the latest trading session, marking a -0.98% move from the prior day.
Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $557.10, marking a -0.34% move from the previous day.
Steris (STE) Up 1.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.